HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Perfect Corp. Highlights Results Of AR-Based Nail Color Sampling At Sally Hansen

Executive Summary

Sally Hansen has seen a 300% increase in shades viewed on its website, and a 120% increase in intent to buy, since it introduced Perfect Corp.’s AR-based virtual try-on tool, the beauty tech firm says. French nail-color specialist Manicurist is the latest to partner with Perfect for its Green Flash brand.

You may also be interested in...



Brick-And-Mortar Stores Adopting E-Commerce Elements For Enhanced Beauty Shopping

Beauty retailers are integrating features in-store that have proven effective in the online shopping realm, creating a richer, more personalized experience from the time consumers walk in the store, says Marie Driscoll, a managing director at Coresight Research.

‘You’re Late, Hurry’: Beauty And Personal Care Leaders Say Time To Adopt AI/AR Is Now

Coty, Inc. and Colgate-Palmolive Company innovation heads say their AI and AR-based digital tools for virtual try-on and other personalized services are transforming shopper expectations. The companies shared their experiences and advice at Perfect Corp.’s 2023 Global Beauty and Fashion Tech Forum.

E.l.f. Beauty Posts ESG Stats; IFF Opens Singapore Innovation Center; Beauty News In Brief

E.l.f. Beauty’s inaugural Impact Report, IFF’s $30m investment in Singapore, Shiseido Europe’s acquisition of skin microbiome product specialist Gallinée, and more beauty news in brief.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS153692

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel